Zebrafish Toxicology experimental platform

Safety screenings

Long-term toxicity can be predicted from studies with early life-stages, a good reason why using  zebrafish larvae in toxicology screening.

ZeClinics will initiate every molecule safety study by testing its Acute Toxicity. This assay will allow the assessing of its possible lethality and teratogenicity. On the other hand, by testing a range of 5 logarithmic concentrations, it will provide values of LC50, EC50 and NOEC. Zebrafish embryos from these treatments can be used to test ADME (Biodisponibility) of any given molecule (Service available upon request).

To warrant the safety of any given molecule, and once the NOEC value is established, ZeClinics can proceed to test the putative toxic effects on specific tissues known to be affected by novel drugs – i.e.: Liver (Hepatotoxicity), Heart (Cardiotoxicity) or CNS (Neurotoxicity).

Acute toxicity and teratogenicity

Fact: Short term drug toxicity can be predicted from studies performed with animal models at early life-stages.

Aim: Analysis of severe short-term effects and the ADME of a new drug

Method: Incubation of zebrafish embryos in 5 different logarithmic concentrations of the molecule of interest. Determination of the following parameters at different time-points (24, 48 and 96hpf) of development: EC50, LC50, NOEC (No observed effect concentration), LOEC (Lowest observed effect concentration). Therefore, several parameters of embryopathy and teratogenic endpoints are analyzed.

Chronic Toxicity

Fact: Long term drug toxicity can be predicted from studies performed with animal models at early life-stages.

Aim: Analysis of severe long-term effects of a new drug.

Method: The chronic assay started with zebrafish larvae aged 6 days postfertilization (dpf), at the onset of exogenous feeding, and lasted 23 days, broadly corresponding to the end of the larval period. The assay was run in static conditions with daily renewal of the medium. Every morning, larvae were transferred to clean experimental units filled with freshly prepared test solutions at the same temperature and returned to the system.


After the Acute toxicity treatment, entire embryos and water, in which the embryos have been treated, can be isolated for testing compound presence (biodisponibility). Depending on the molecule synthesis origin, the samples will be analyzed with NMR or Mass spectrometry. A concentration curve of the molecule can be measured in tissues and water, and also the presence of possible metabolites.


Fact: Cardiac dysfunctions represent one of the most important types of drug toxicity; the majority of drugs that result in clinical problems interfere with the human Ether-`a-go-go Related Gene (hERG) channel, blocking the rapid component delayed rectifier potassium current.

Aim: Analysis of cardiac effect of the drug in zebrafish larvae.

Method: Larvae of 120 hours post fertilization (hpf) of transgenic GFP heart fishes are incubated with the NOEC concentration of the molecule of interest during 4h and video recorded for heart physiology. Videos are analyzed with ZeCardio software for the presence of the several cardiac dysfunctions


Fact: Drug-induced neurological effects are remarkably common and are among the most frequent reasons for poor drug compliance.

Aim: Analysis of neurotoxic effects of drugs in zebrafish larvae.

Method: Larvae of transgenic zebrafish expressing GFP in a sub-population of neurons will be exposed to the NOEC concentration of the molecule of interest from 3 dfp to 4 dpf. Larvae are fixed, and GFP neurons of defined region in the rosencephalon are counted. Simultaneusly, basal locomotor activity is also measured with more alive treated larvae.


Fact: New chemicals often cause hepatotoxicity in the process of drug-discovery.

Aim: Analysis of the effects on the liver of drugs in zebrafish larvae.

Method: Embryos of transgenic RFP liver from 5 days post fertilization (dpf) to 7 dpf are incubated with the NOEC concentration of the molecule of interest. Larvae are fixed and analyzed for the several outputs indicative of hepatotoxicity.


Just tell us your biological/pharmacological question and we propose and run the best zebrafish-based scientific methodology and provide reliable results. Rare diseases, gene functions, biological pathways, drug-target interaction, drug accumulations and much more can be developed and studied in zebrafish.


Request information about ZeTOX: